Teva Pharmaceutical Industries Limited (
) will begin trading ex-dividend on February 19, 2013. A cash
dividend payment of $0.31 per share is scheduled to be paid on
March 07, 2013. Shareholders who purchased TEVA stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 20.62% increase over the prior quarter.
The previous trading day's last sale of TEVA was $38.73,
representing a -16.49% decrease from the 52 week high of $46.38 and
a 5.73% increase over the 52 week low of $36.63.
TEVA is a part of the Consumer Durables sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). TEVA's current earnings per share, an indicator of a company's
profitability, is $2.24. Zacks Investment Research reports TEVA's
forecasted earnings growth in 2013 as -4.92%, compared to an
industry average of -13.7%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to TEVA through an Exchange
Traded Fund [ETF]?
The following ETF(s) have TEVA as a top-10 holding:
- iShares MSCI ACWI ex US Health Care Sector Index Fund (
- iShares MSCI Israel Capped Investable Market Index Fund (
- BLDRS Europe 100 ADR Index Fund (
The top-performing ETF of this group is ADRU with an increase of
15.39% over the last 100 days. AXHE has the highest percent
weighting of TEVA at 3.02%.